Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile gigantic failures like hedge funds’ recent losses in Valeant. Let’s take a closer look at what the funds we track think about Blue Capital Reinsurance Holdings Ltd (NYSE:BCRH) in this article.
Blue Capital Reinsurance Holdings Ltd (NYSE:BCRH) shares haven’t seen a lot of action during the third quarter and, overall, hedge fund sentiment was unchanged, as the stock remained almost flat in the same period. The stock was in 4 hedge funds’ portfolios at the end of the third quarter of 2015. At the end of this article we will also compare BCRH to other stocks, including NV5 Holdings Inc (NASDAQ:NVEE), Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE), and Agile Therapeutics Inc (NASDAQ:AGRX) to get a better sense of its popularity.
Today there are a multitude of formulas investors employ to assess publicly traded companies. Some of the most innovative formulas are hedge fund and insider trading interest. Our researchers have shown that, historically, those who follow the best picks of the elite investment managers can trounce their index-focused peers by a significant margin (see the details here).
With all of this in mind, we’re going to view the recent action surrounding Blue Capital Reinsurance Holdings Ltd (NYSE:BCRH).
How are hedge funds trading Blue Capital Reinsurance Holdings Ltd (NYSE:BCRH)?
At the end of the third quarter, a total of 4 of the hedge funds tracked by Insider Monkey held long positions in this stock. With hedgies’ capital changing hands, there exists a select group of key hedge fund managers who were upping their stakes meaningfully (or already accumulated large positions).
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Dmitry Balyasny’s Balyasny Asset Management has the biggest position in Blue Capital Reinsurance Holdings Ltd (NYSE:BCRH), worth close to $1.8 million, comprising less than 0.1%% of its total 13F portfolio. On Balyasny Asset Management’s heels is Brian Taylor’s Pine River Capital Management, with a $1.6 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Remaining professional money managers with similar optimism contain Chuck Royce’s Royce & Associates and Jim Simons’ Renaissance Technologies.